French Cardiology Society clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 0 with minor changes only.

1. Notable

   ELASTOCARDIO2 · Noninvasive Elastography Evaluation of…ELASTOCARDIO2 · Noninvasive Elastography Evaluation of Myocardial Stiffness · Isolated Diastolic Heart Failure: New Diagnostic Tool?

   Primary and study completion pushed from Dec 31, 2025 to Dec 31, 2026

   Also in this update: Primary endpoint(s) modified; Enrollment increased: 90 → 140 participants

   French Cardiology Society·Not applicable· NCT03895541· Registry history of NCT03895541 on ClinicalTrials.gov (opens the registry)

   Oct 9, 2026

2. Notable

   COEUR · Women's Heart: Impact of Ultra-endurance and Hormonal…COEUR · Women's Heart: Impact of Ultra-endurance and Hormonal Profile on Cardiac and Systemic Inflammatory Parameters in Female Runners

   Primary and study completion pushed from Sep 30, 2026 to Sep 30, 2027

   French Cardiology Society·Not applicable· NCT07372859· Registry history of NCT07372859 on ClinicalTrials.gov (opens the registry)

   Oct 9, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.